CVE-2018-0108

Exploitation

Assessed, none found. CISA's assessment recorded neither public exploit code nor evidence of exploitation when it was made.

SSVC decision

• ExploitationnoneCISA recorded no public exploit code and no evidence of exploitation.
• AutomatableyesAn attacker can reliably automate reconnaissance through exploitation, so this scales.
• Technical ImpactpartialSuccessful exploitation gives limited control of the vulnerable component.

CISA publishes the decision points, not a final SSVC decision. The decision also depends on mission and well-being impact, which is a property of your deployment rather than of the vulnerability.

EPSS probability

1.83% probability of exploitation activity in the next 30 days.

EPSS percentile

Ranks above 77.4% of scored records. A rank, not a probability.

NVD base score

5.3 (CVSS v3.x), scored by the NVD independently of the CNA.

NVD CVSS vector

CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

NVD analysis status

Modified. NVD last modified this record on 2026-06-17.

Red Hat severity

No Red Hat rating. Red Hat rates the CVEs that affect its products.

Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.

Published

2018-01-18 06:00Z8 YR AGO

Last updated

2024-12-02 21:35Z1 YR AGO

Reserved

2017-11-27

Assigning CNA

cisco

Record state

PUBLISHED

Severity

Not rated by the issuing CNA

CNA CVSS vector

Not published by the issuing CNA

Weaknesses

• CWE-611Improper Restriction of XML External Entity ReferenceBase

Data version

5.1

Document digest

b3099b2f7fc346824a1c27b8c488a555a55cac14ea062ff88e97b9880e6e8bcd

• www.securitytracker.com1040238http://www.securitytracker.com/id/1040238vdb-entryx_refsource_SECTRACK
• www.securityfocus.com102720http://www.securityfocus.com/bid/102720vdb-entryx_refsource_BID
• tools.cisco.comhttps://tools.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-20180117-wmsx_refsource_CONFIRM